Terozesta Tablet

Composition of Terozesta Tablet

Terozesta Tablet contains Dienogest (2mg). It belongs to the Parathyroid hormone (PTH) analog class of medicines.

Uses of Terozesta Tablet

Treatment of osteoporosis in postmenopausal women and men at high risk of fracture; glucocorticoid-induced osteoporosis at high risk of fracture; increases bone mass and reduces fracture risk in severe osteoporosis as prescribed.

Key benefits

• Builds new bone and increases bone mineral density
• Reduces risk of vertebral and non-vertebral fractures
• Helpful in severe/high-risk osteoporosis
• Improves bone strength when other therapies are inadequate

How Terozesta Tablet works

Teriparatide is an anabolic (bone-building) agent. Intermittent administration stimulates osteoblast activity more than osteoclast activity, leading to new bone formation and increased bone mineral density, thereby lowering fracture risk.

How to take Terozesta Tablet

Use exactly as prescribed by a doctor. Usually given as a once-daily subcutaneous injection; do not inject into a vein or muscle. Take adequate calcium and vitamin D as advised. If dizziness occurs after injection, sit/lie down; learn correct injection technique and safe needle disposal.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

If you miss a dose of Terozesta 2mg Tablet, please consult your doctor.

If you take too much

An overdose of this medicine may cause nausea, vomiting and withdrawal bleeding. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Terozesta Tablet

Most side effects of Terozesta are mild and settle as the body adjusts. Reported side effects include:

• Nausea
• dizziness
• headache
• leg cramps
• injection site pain/redness
• fatigue
• transient increase in blood calcium

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Terozesta Tablet

Warnings and precautions

Prescription-only medicine. Not recommended in patients with hypercalcemia, severe kidney impairment, bone metastases or skeletal malignancy, Paget’s disease of bone, unexplained elevated alkaline phosphatase, prior radiation therapy involving the skeleton, or in children/young adults with open epiphyses. Use with caution in kidney stones/urolithiasis; monitor calcium if advised. Limit total duration of therapy as per prescribing information; follow-up for bone health is required. Seek urgent care for signs of allergic reaction, severe dizziness/fainting, or symptoms of high calcium.

Do not take Terozesta if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for people with a history of blood clots, certain hormone-sensitive cancers, or active liver disease. Several are contraindicated in pregnancy.

Interactions with other medicines

Digoxin (risk of arrhythmias with hypercalcemia), calcium/vitamin D supplements (may increase hypercalcemia risk), thiazide diuretics (may increase calcium), other medicines affecting calcium or bone metabolism (as directed by physician).

How to store Terozesta Tablet

Store refrigerated at 2–8°C. Do not freeze. Protect from light. Keep the container/pen capped; do not use if frozen or if solution is cloudy/has particles. Keep out of reach of children.

Expert advice for Terozesta Tablet

You have been prescribed Terozesta 2mg Tablet for the treatment of pelvic pain associated with endometriosis. Take it without any break, preferably at the same time every day. Do not use hormonal contraceptives while taking this medicine. If required, use non-hormonal methods of contraception such as condoms. You may experience infrequent or irregular menstrual bleeding patterns. Consult your doctor if this bothers you. Do not use Terozesta 2mg Tablet if you are pregnant or breastfeeding.

Manufacturer and class

Manufacturer:

MANKIND (PHARMA)

Therapeutic class:

Anti-osteoporotic (Bone anabolic agent)

Drug class:

Parathyroid hormone (PTH) analog

Chemical class:

Oxosteroids